Pseudohyperkalemia and Pseudohyponatremia in Two Children with T-Cell Acute Lymphoblastic Leukemia

Zelda Ghersin1, Neil D Fernandes1, Amanda Winkler1

  • 1Department of Pediatrics, Massachusetts General Hospital for Children, Harvard Medical School, Boston, MA.

The Journal of Pediatrics
|January 25, 2021
PubMed

Insights

Pseudohyperkalemia and pseudohyponatremia are falsely elevated or decreased electrolyte levels caused by high cell counts in blood disorders. Correlating plasma and whole blood electrolyte results is crucial to avoid incorrect medical treatment in leukemia patients.

Area of Science:

  • Hematology
  • Clinical Chemistry
  • Pediatric Oncology

Background:

  • Pseudohyperkalemia and pseudohyponatremia are laboratory artifacts.
  • These can occur in patients with hematologic disorders characterized by high cell counts.
  • Factitious electrolyte measurements may lead to inappropriate clinical interventions.

Observation:

  • Two pediatric patients with leukemia presented with both pseudohyperkalemia and pseudohyponatremia.
  • These electrolyte disturbances were linked to the high cell counts associated with their leukemia.

Findings:

  • The study highlights the critical importance of validating electrolyte measurements.
  • Correlation between plasma and whole blood electrolyte values is essential for accurate diagnosis.
  • Failure to correlate results can lead to misdiagnosis and improper treatment.

Implications:

  • Accurate electrolyte measurement is vital for appropriate patient management in hematologic malignancies.
  • Clinicians should be aware of potential electrolyte measurement interferences in leukemia.
  • Implementing comparative testing (plasma vs. whole blood) can prevent treatment errors.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
106
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
128
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
1.9K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
339
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
103
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
102